TABLE 3.
Treatment | Cytokine level (pg/ml) |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
18 h |
72 h |
|||||||||||
TNF-α | IL-6 | MCP-1 | KC | IL-1β | IL-10 | TNF-α | IL-6 | MCP-1 | KC | IL-1β | IL-10 | |
None | <5b | <5b | <10b | 22 ± 10 | <5b | <5b | <5b | <5b | <10b | 22 ± 10 | <5b | <5b |
400 μg/ml LiCl | <5b | <5b | <10b | 23 ± 8 | <5b | <5b | <5b | <5b | <10b | 25 ± 8 | <5b | <5b |
NK-9 | 164 ± 10 | 888 ± 68 | 954 ± 216 | 878 ± 49 | <5b | 46 ± 11 | 251 ± 15 | 15,898 ± 99 | 988 ± 216 | 2,461 ± 98 | <5b | 630 ± 55 |
NK-9 + 10 μg/ml LiCl | 29 ± 10 | 364 ± 89 | 1,281 ± 87 | 350 ± 98 | <5b | 12 ± 5 | 80 ± 11 | 860 ± 279 | 398 ± 78 | 521 ± 98 | <5b | 23 ± 15 |
NK-9 + 100 μg/ml LiCl | 33 ± 2 | 273 ± 95 | 868 ± 49 | 430 ± 49 | <5b | 16 ± 3 | 59 ± 8 | 1,019 ± 106 | 152 ± 58 | 596 ± 23 | <5b | 17 ± 5 |
NK-9 + 400 μg/ml LiCl | 13 ± 3c | 90 ± 11c | 299 ± 30c | 187 ± 21c | <5b | <5b | 5 ± 1c | 21 ± 5c | 18 ± 4c | 53 ± 10c | <5b | <5b |
Groups of four mice were inoculated, via the intragastric route, with 5 × 108 K. pneumoniae NK-9 cells per mouse. Various concentrations of LiCl were administered immediately postinfection by addition to the drinking water. The mice were sacrificed at 18 or 72 h postinfection, and cytokine expression in sera was detected with CBA flex sets. Data are presented as mean ± standard deviation. The statistical analysis was performed using repeated-measures ANOVA.
Minimal cytokine concentration detected using a CBA flex kit.
P < 0.05, compared with results for NK-9-treated mice.